Apollo Hospitals Enterprise Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 26, 2025, 4:56 pm

Market Cap	1,02,122 Cr.
Current Price	7,100
High / Low	7,545/6,001
Stock P/E	70.6
Book Value	571
Dividend Yield	0.23 %
ROCE	17.1 %
ROE	19.1 %
Face Value	5.00
PEG Ratio	1.23

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Apollo Hospitals Enterprise Ltd

Competitors of Apollo Hospitals Enterprise Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
NG Industries Ltd	51.0 Cr.	152	206/145	6.59	115	2.30 %	23.6 %	20.7 %	10.0
Global Longlife Hospital and Research Ltd	26.2 Cr.	25.0	46.4/18.3	131	25.5	0.00 %	1.16 %	0.76 %	10.0
Gian Lifecare Ltd	15.3 Cr.	14.8	27.0/12.1	3.76	19.2	0.00 %	29.2 %	24.6 %	10.0
Fortis Malar Hospitals Ltd	136 Cr.	72.5	98.7/51.0	348	16.1	58.6 %	0.83 %	0.56 %	10.0
Family Care Hospitals Ltd	24.1 Cr.	4.46	9.50/3.40	0.79	2.49	0.00 %	77.2 %	84.8 %	10.0
Industry Average	26,923.14 Cr	736.79		114.01	92.57	2.78%	15.55%	14.36%	9.08

All Competitor Stocks of Apollo Hospitals Enterprise Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	3,546	3,796	4,251	4,264	4,302	4,418	4,847	4,851	4,944	5,086	5,589	5,527	5,592
Expenses	3,083	3,317	3,699	3,780	3,814	3,909	4,219	4,237	4,303	4,410	4,774	4,765	4,822
Operating Profit	463	479	552	484	488	509	628	614	640	675	816	762	770
OPM %	13%	13%	13%	11%	11%	12%	13%	13%	13%	13%	15%	14%	14%
Other Income	34	16	23	35	20	34	26	29	37	49	44	69	72
Interest	95	93	93	100	95	106	111	113	119	116	118	110	115
Depreciation	166	148	155	153	159	167	163	167	190	177	184	185	211
Profit before tax	236	254	327	266	254	270	379	363	368	430	557	536	516
Tax %	59%	-27%	35%	39%	43%	36%	34%	30%	30%	27%	29%	29%	20%
Net Profit	97	324	213	162	146	173	249	254	258	316	396	379	414
EPS in Rs	6.27	22.06	14.19	10.68	10.05	11.59	16.20	17.06	17.65	21.23	26.34	25.89	27.10

Last Updated: May 31, 2025, 9:49 am

Below is a detailed analysis of the quarterly data for Apollo Hospitals Enterprise Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 5,592.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,527.00 Cr. (Dec 2024) to 5,592.00 Cr., marking an increase of 65.00 Cr..
For Expenses, as of Mar 2025, the value is 4,822.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,765.00 Cr. (Dec 2024) to 4,822.00 Cr., marking an increase of 57.00 Cr..
For Operating Profit, as of Mar 2025, the value is 770.00 Cr.. The value appears strong and on an upward trend. It has increased from 762.00 Cr. (Dec 2024) to 770.00 Cr., marking an increase of 8.00 Cr..
For OPM %, as of Mar 2025, the value is 14.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 14.00%.
For Other Income, as of Mar 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 69.00 Cr. (Dec 2024) to 72.00 Cr., marking an increase of 3.00 Cr..
For Interest, as of Mar 2025, the value is 115.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 110.00 Cr. (Dec 2024) to 115.00 Cr., marking an increase of 5.00 Cr..
For Depreciation, as of Mar 2025, the value is 211.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 185.00 Cr. (Dec 2024) to 211.00 Cr., marking an increase of 26.00 Cr..
For Profit before tax, as of Mar 2025, the value is 516.00 Cr.. The value appears to be declining and may need further review. It has decreased from 536.00 Cr. (Dec 2024) to 516.00 Cr., marking a decrease of 20.00 Cr..
For Tax %, as of Mar 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Dec 2024) to 20.00%, marking a decrease of 9.00%.
For Net Profit, as of Mar 2025, the value is 414.00 Cr.. The value appears strong and on an upward trend. It has increased from 379.00 Cr. (Dec 2024) to 414.00 Cr., marking an increase of 35.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 27.10. The value appears strong and on an upward trend. It has increased from 25.89 (Dec 2024) to 27.10, marking an increase of 1.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 6:07 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	4,357	5,129	6,150	7,256	8,243	9,617	11,247	10,560	14,663	16,612	19,059	21,794
Expenses	3,681	4,392	5,465	6,522	7,442	8,548	9,656	9,420	12,474	14,548	16,665	18,772
Operating Profit	676	737	684	734	801	1,070	1,591	1,140	2,189	2,065	2,394	3,022
OPM %	16%	14%	11%	10%	10%	11%	14%	11%	15%	12%	13%	14%
Other Income	18	47	92	60	24	26	222	103	368	75	105	233
Interest	119	118	180	257	295	327	533	449	379	381	449	458
Depreciation	168	212	264	314	359	396	620	573	601	615	687	758
Profit before tax	407	455	332	222	171	373	660	221	1,578	1,144	1,362	2,039
Tax %	25%	29%	29%	41%	65%	47%	34%	38%	30%	22%	33%	26%
Net Profit	315	335	235	131	60	200	432	137	1,108	844	935	1,505
EPS in Rs	22.77	24.43	16.99	15.88	8.44	16.96	32.70	10.46	73.42	56.97	62.50	100.56
Dividend Payout %	25%	24%	35%	38%	59%	35%	18%	29%	16%	26%	26%	28%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	6.35%	-29.85%	-44.26%	-54.20%	233.33%	116.00%	-68.29%	708.76%	-23.83%	10.78%	60.96%
Change in YoY Net Profit Growth (%)	0.00%	-36.20%	-14.40%	-9.94%	287.53%	-117.33%	-184.29%	777.05%	-732.59%	34.61%	50.18%

Apollo Hospitals Enterprise Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	16%
5 Years:	14%
3 Years:	14%
TTM:	14%

Compounded Profit Growth
10 Years:	16%
5 Years:	37%
3 Years:	20%
TTM:	65%

Stock Price CAGR
10 Years:	19%
5 Years:	41%
3 Years:	26%
1 Year:	21%

Return on Equity
10 Years:	11%
5 Years:	14%
3 Years:	16%
Last Year:	19%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:29 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	70	70	70	70	70	70	70	72	72	72	72	72
Reserves	2,907	3,102	3,262	3,244	3,182	3,264	3,270	4,531	5,551	6,126	6,864	8,140
Borrowings	1,344	1,992	2,834	3,125	3,427	3,673	3,596	4,160	4,068	4,332	5,333	7,864
Other Liabilities	1,029	1,296	1,195	1,665	1,917	2,159	4,354	2,629	3,570	3,886	4,474	4,581
Total Liabilities	5,350	6,459	7,360	8,103	8,596	9,166	11,289	11,392	13,261	14,416	16,742	20,657
Fixed Assets	2,681	3,244	3,997	4,591	4,773	4,982	7,432	6,778	8,296	8,520	9,664	11,138
CWIP	491	533	562	347	712	822	236	234	46	610	873	771
Investments	322	311	352	406	352	462	434	1,343	816	574	986	2,487
Other Assets	1,855	2,372	2,448	2,759	2,759	2,901	3,187	3,037	4,104	4,712	5,219	6,261
Total Assets	5,350	6,459	7,360	8,103	8,596	9,166	11,289	11,392	13,261	14,416	16,742	20,657

Below is a detailed analysis of the balance sheet data for Apollo Hospitals Enterprise Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 72.00 Cr..
For Reserves, as of Mar 2025, the value is 8,140.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,864.00 Cr. (Mar 2024) to 8,140.00 Cr., marking an increase of 1,276.00 Cr..
For Borrowings, as of Mar 2025, the value is 7,864.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5,333.00 Cr. (Mar 2024) to 7,864.00 Cr., marking an increase of 2,531.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 4,581.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,474.00 Cr. (Mar 2024) to 4,581.00 Cr., marking an increase of 107.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 20,657.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16,742.00 Cr. (Mar 2024) to 20,657.00 Cr., marking an increase of 3,915.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 11,138.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,664.00 Cr. (Mar 2024) to 11,138.00 Cr., marking an increase of 1,474.00 Cr..
For CWIP, as of Mar 2025, the value is 771.00 Cr.. The value appears to be declining and may need further review. It has decreased from 873.00 Cr. (Mar 2024) to 771.00 Cr., marking a decrease of 102.00 Cr..
For Investments, as of Mar 2025, the value is 2,487.00 Cr.. The value appears strong and on an upward trend. It has increased from 986.00 Cr. (Mar 2024) to 2,487.00 Cr., marking an increase of 1,501.00 Cr..
For Other Assets, as of Mar 2025, the value is 6,261.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,219.00 Cr. (Mar 2024) to 6,261.00 Cr., marking an increase of 1,042.00 Cr..
For Total Assets, as of Mar 2025, the value is 20,657.00 Cr.. The value appears strong and on an upward trend. It has increased from 16,742.00 Cr. (Mar 2024) to 20,657.00 Cr., marking an increase of 3,915.00 Cr..

Notably, the Reserves (8,140.00 Cr.) exceed the Borrowings (7,864.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	373	470	597	623	537	905	1,293	1,265	1,696	1,377	1,920	2,136
Cash from Investing Activity +	-356	-759	-888	-1,152	-405	-711	-289	-880	-747	-857	-1,537	-3,381
Cash from Financing Activity +	-63	392	330	477	-108	-215	-910	-340	-792	-633	-311	1,317
Net Cash Flow	-46	103	39	-52	24	-20	94	44	158	-113	72	73

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	675.00	736.00	682.00	731.00	798.00	-2.00	-2.00	-3.00	-2.00	-2.00	-3.00	-4.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	46	44	43	36	38	37	39	33	46	44	49	48
Inventory Days	43	47	50	49	47	51	46	49	16	21	17	17
Days Payable	53	55	59	66	51	55	56	60	74	79	82	88
Cash Conversion Cycle	36	36	34	19	34	33	29	22	-12	-14	-16	-23
Working Capital Days	17	28	30	27	30	25	16	9	12	13	18	2
ROCE %	13%	12%	12%	9%	8%	7%	10%	14%	8%	17%	14%	15%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	29.82%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%
FIIs	51.54%	52.41%	50.81%	48.48%	49.09%	47.94%	46.96%	47.93%	46.15%	46.25%	45.63%	43.92%
DIIs	12.28%	12.17%	12.93%	15.64%	15.28%	16.56%	17.76%	17.02%	18.59%	18.87%	19.55%	21.13%
Government	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%
Public	6.14%	5.86%	6.70%	6.32%	6.07%	5.94%	5.72%	5.49%	5.68%	5.32%	5.26%	5.38%
No. of Shareholders	98,452	99,135	1,26,226	1,46,320	1,35,923	1,31,636	1,31,937	1,20,030	1,31,565	1,19,578	1,30,664	1,27,754

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HDFC Flexi Cap Fund - Regular Plan	3,207,166	4.28	2037.5	3,207,166	2025-04-22 17:25:42	0%
SBI Nifty 50 ETF	1,822,347	0.67	1157.73	1,822,347	2025-04-22 17:25:42	0%
Axis ELSS Tax Saver Fund	1,426,357	2.7	906.16	1,426,357	2025-04-22 17:25:42	0%
Aditya Birla Sun Life Flexi Cap Fund	950,000	3.08	603.53	950,000	2025-04-22 17:25:42	0%
HDFC ELSS Tax Saver Fund	750,000	3.54	476.47	750,000	2025-04-22 17:25:42	0%
Nippon India Pharma Fund	648,795	5.98	412.18	648,795	2025-04-22 17:25:42	0%
HDFC Focused 30 Fund - Regular Plan	625,000	4.26	397.06	625,000	2025-04-22 17:25:42	0%
Axis Bluechip Fund	622,060	1.21	395.19	622,060	2025-04-22 11:41:35	0%
Axis Focused 25 Fund	593,270	2.72	376.9	593,270	2025-04-22 17:25:42	0%
UTI Nifty 50 ETF	504,646	0.67	320.6	504,646	2025-04-22 17:25:42	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	62.50	56.97	73.42	10.74	32.70
Diluted EPS (Rs.)	62.50	56.97	73.42	10.74	32.70
Cash EPS (Rs.)	111.54	104.51	118.34	49.31	75.75
Book Value[Excl.RevalReserv]/Share (Rs.)	509.07	454.19	408.74	333.96	249.27
Book Value[Incl.RevalReserv]/Share (Rs.)	509.07	454.19	408.74	333.96	249.27
Revenue From Operations / Share (Rs.)	1325.40	1155.25	1019.65	734.35	807.96
PBDIT / Share (Rs.)	173.64	148.81	157.39	82.22	115.96
PBIT / Share (Rs.)	125.87	106.02	115.62	42.37	71.44
PBT / Share (Rs.)	94.75	79.53	109.74	15.35	47.41
Net Profit / Share (Rs.)	63.77	61.72	76.57	9.46	31.24
NP After MI And SOA / Share (Rs.)	62.49	56.96	73.41	10.46	32.67
PBDIT Margin (%)	13.10	12.88	15.43	11.19	14.35
PBIT Margin (%)	9.49	9.17	11.33	5.76	8.84
PBT Margin (%)	7.14	6.88	10.76	2.08	5.86
Net Profit Margin (%)	4.81	5.34	7.50	1.28	3.86
NP After MI And SOA Margin (%)	4.71	4.93	7.19	1.42	4.04
Return on Networth / Equity (%)	12.95	13.21	18.77	3.26	13.62
Return on Capital Employeed (%)	14.97	13.73	15.38	6.49	11.04
Return On Assets (%)	5.36	5.67	8.00	1.31	4.01
Long Term Debt / Equity (X)	0.32	0.31	0.43	0.53	0.85
Total Debt / Equity (X)	0.45	0.43	0.46	0.54	1.00
Asset Turnover Ratio (%)	1.22	0.54	0.55	0.86	1.01
Current Ratio (X)	1.13	1.30	1.73	1.79	1.13
Quick Ratio (X)	1.03	1.19	1.55	1.66	0.81
Dividend Payout Ratio (NP) (%)	24.00	31.15	4.13	25.46	28.38
Dividend Payout Ratio (CP) (%)	13.60	17.79	2.63	5.29	12.01
Earning Retention Ratio (%)	76.00	68.85	95.87	74.54	71.62
Cash Earning Retention Ratio (%)	86.40	82.21	97.37	94.71	87.99
Interest Coverage Ratio (X)	5.56	5.62	5.98	2.63	3.03
Interest Coverage Ratio (Post Tax) (X)	3.04	3.33	3.13	1.17	1.44
Enterprise Value (Cr.)	93953.52	64237.57	66797.88	43713.80	18852.27
EV / Net Operating Revenue (X)	4.93	3.87	4.56	4.14	1.68
EV / EBITDA (X)	37.63	30.02	29.51	36.97	11.68
MarketCap / Net Operating Revenue (X)	4.79	3.73	4.43	3.95	1.41
Retention Ratios (%)	75.99	68.84	95.86	74.53	71.61
Price / BV (X)	13.17	10.00	11.55	9.07	4.74
Price / Net Operating Revenue (X)	4.79	3.73	4.43	3.95	1.41
EarningsYield	0.01	0.01	0.01	0.00	0.02

After reviewing the key financial ratios for Apollo Hospitals Enterprise Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 24, the value is 62.50. This value is within the healthy range. It has increased from 56.97 (Mar 23) to 62.50, marking an increase of 5.53.
For Diluted EPS (Rs.), as of Mar 24, the value is 62.50. This value is within the healthy range. It has increased from 56.97 (Mar 23) to 62.50, marking an increase of 5.53.
For Cash EPS (Rs.), as of Mar 24, the value is 111.54. This value is within the healthy range. It has increased from 104.51 (Mar 23) to 111.54, marking an increase of 7.03.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 509.07. It has increased from 454.19 (Mar 23) to 509.07, marking an increase of 54.88.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 509.07. It has increased from 454.19 (Mar 23) to 509.07, marking an increase of 54.88.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,325.40. It has increased from 1,155.25 (Mar 23) to 1,325.40, marking an increase of 170.15.
For PBDIT / Share (Rs.), as of Mar 24, the value is 173.64. This value is within the healthy range. It has increased from 148.81 (Mar 23) to 173.64, marking an increase of 24.83.
For PBIT / Share (Rs.), as of Mar 24, the value is 125.87. This value is within the healthy range. It has increased from 106.02 (Mar 23) to 125.87, marking an increase of 19.85.
For PBT / Share (Rs.), as of Mar 24, the value is 94.75. This value is within the healthy range. It has increased from 79.53 (Mar 23) to 94.75, marking an increase of 15.22.
For Net Profit / Share (Rs.), as of Mar 24, the value is 63.77. This value is within the healthy range. It has increased from 61.72 (Mar 23) to 63.77, marking an increase of 2.05.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 62.49. This value is within the healthy range. It has increased from 56.96 (Mar 23) to 62.49, marking an increase of 5.53.
For PBDIT Margin (%), as of Mar 24, the value is 13.10. This value is within the healthy range. It has increased from 12.88 (Mar 23) to 13.10, marking an increase of 0.22.
For PBIT Margin (%), as of Mar 24, the value is 9.49. This value is below the healthy minimum of 10. It has increased from 9.17 (Mar 23) to 9.49, marking an increase of 0.32.
For PBT Margin (%), as of Mar 24, the value is 7.14. This value is below the healthy minimum of 10. It has increased from 6.88 (Mar 23) to 7.14, marking an increase of 0.26.
For Net Profit Margin (%), as of Mar 24, the value is 4.81. This value is below the healthy minimum of 5. It has decreased from 5.34 (Mar 23) to 4.81, marking a decrease of 0.53.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.71. This value is below the healthy minimum of 8. It has decreased from 4.93 (Mar 23) to 4.71, marking a decrease of 0.22.
For Return on Networth / Equity (%), as of Mar 24, the value is 12.95. This value is below the healthy minimum of 15. It has decreased from 13.21 (Mar 23) to 12.95, marking a decrease of 0.26.
For Return on Capital Employeed (%), as of Mar 24, the value is 14.97. This value is within the healthy range. It has increased from 13.73 (Mar 23) to 14.97, marking an increase of 1.24.
For Return On Assets (%), as of Mar 24, the value is 5.36. This value is within the healthy range. It has decreased from 5.67 (Mar 23) to 5.36, marking a decrease of 0.31.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.32. This value is within the healthy range. It has increased from 0.31 (Mar 23) to 0.32, marking an increase of 0.01.
For Total Debt / Equity (X), as of Mar 24, the value is 0.45. This value is within the healthy range. It has increased from 0.43 (Mar 23) to 0.45, marking an increase of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.22. It has increased from 0.54 (Mar 23) to 1.22, marking an increase of 0.68.
For Current Ratio (X), as of Mar 24, the value is 1.13. This value is below the healthy minimum of 1.5. It has decreased from 1.30 (Mar 23) to 1.13, marking a decrease of 0.17.
For Quick Ratio (X), as of Mar 24, the value is 1.03. This value is within the healthy range. It has decreased from 1.19 (Mar 23) to 1.03, marking a decrease of 0.16.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 24.00. This value is within the healthy range. It has decreased from 31.15 (Mar 23) to 24.00, marking a decrease of 7.15.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 13.60. This value is below the healthy minimum of 20. It has decreased from 17.79 (Mar 23) to 13.60, marking a decrease of 4.19.
For Earning Retention Ratio (%), as of Mar 24, the value is 76.00. This value exceeds the healthy maximum of 70. It has increased from 68.85 (Mar 23) to 76.00, marking an increase of 7.15.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 86.40. This value exceeds the healthy maximum of 70. It has increased from 82.21 (Mar 23) to 86.40, marking an increase of 4.19.
For Interest Coverage Ratio (X), as of Mar 24, the value is 5.56. This value is within the healthy range. It has decreased from 5.62 (Mar 23) to 5.56, marking a decrease of 0.06.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.04. This value is within the healthy range. It has decreased from 3.33 (Mar 23) to 3.04, marking a decrease of 0.29.
For Enterprise Value (Cr.), as of Mar 24, the value is 93,953.52. It has increased from 64,237.57 (Mar 23) to 93,953.52, marking an increase of 29,715.95.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.93. This value exceeds the healthy maximum of 3. It has increased from 3.87 (Mar 23) to 4.93, marking an increase of 1.06.
For EV / EBITDA (X), as of Mar 24, the value is 37.63. This value exceeds the healthy maximum of 15. It has increased from 30.02 (Mar 23) to 37.63, marking an increase of 7.61.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 3.73 (Mar 23) to 4.79, marking an increase of 1.06.
For Retention Ratios (%), as of Mar 24, the value is 75.99. This value exceeds the healthy maximum of 70. It has increased from 68.84 (Mar 23) to 75.99, marking an increase of 7.15.
For Price / BV (X), as of Mar 24, the value is 13.17. This value exceeds the healthy maximum of 3. It has increased from 10.00 (Mar 23) to 13.17, marking an increase of 3.17.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 3.73 (Mar 23) to 4.79, marking an increase of 1.06.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Apollo Hospitals Enterprise Ltd as of July 4, 2025 is: 6,173.93

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 4, 2025, Apollo Hospitals Enterprise Ltd is Overvalued by 13.04% compared to the current share price 7,100.00

Intrinsic Value of Apollo Hospitals Enterprise Ltd as of July 4, 2025 is: 9,708.24

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 4, 2025, Apollo Hospitals Enterprise Ltd is Undervalued by 36.74% compared to the current share price 7,100.00

Last 5 Year EPS CAGR: 57.25%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of 18.92, which is a positive sign. The company has higher reserves (4,453.58 cr) compared to borrowings (3,812.33 cr), indicating strong financial stability. The company has shown consistent growth in sales (10.83 cr) and profit (237.17 cr) over the years.	The stock has a low average ROCE of 11.58%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 14.83, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Apollo Hospitals Enterprise Ltd:
1. Net Profit Margin: 4.81%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 14.97% (Industry Average ROCE: 15.55%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 12.95% (Industry Average ROE: 14.36%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 3.04
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.03
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 70.6 (Industry average Stock P/E: 114.01)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.45
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Apollo Hospitals Enterprise Ltd. is a Public Limited Listed company incorporated on 05/12/1979 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L85110TN1979PLC008035 and registration number is 008035. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 8202.10 Cr. and Equity Capital is Rs. 71.90 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	No.19, Bishop Gardens, Chennai (Madras) Tamil Nadu 600028	investor.relations@apollohospitals.com https://www.apollohospitals.com

Management
Name	Position Held
Dr. Prathap C Reddy	Founder & Executive Chairman
Mrs. Preetha Reddy	Executive Vice Chairperson
Mrs. Suneeta Reddy	Managing Director
Mrs. Sangita Reddy	Joint Managing Director
Dr. Som Mittal	Independent Director
Mrs. V Kavitha Dutt	Independent Director
Dr. Murali Doraiswamy	Independent Director
Mrs. Rama Bijapurkar	Independent Director
Mr. Vinayak Chatterjee	Independent Director
Mr. M B N Rao	Lead Independent Director

FAQ

What is the intrinsic value of Apollo Hospitals Enterprise Ltd?

Apollo Hospitals Enterprise Ltd's intrinsic value (as of 04 July 2025) is 6173.93 — 13.04% lower the current market price of 7,100.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,02,122 Cr. market cap, FY2025-2026 high/low of 7,545/6,001, reserves of 8,140 Cr, and liabilities of 20,657 Cr.

What is the Market Cap of Apollo Hospitals Enterprise Ltd?

The Market Cap of Apollo Hospitals Enterprise Ltd is 1,02,122 Cr..

What is the current Stock Price of Apollo Hospitals Enterprise Ltd as on 04 July 2025?

The current stock price of Apollo Hospitals Enterprise Ltd as on 04 July 2025 is 7,100.

What is the High / Low of Apollo Hospitals Enterprise Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Apollo Hospitals Enterprise Ltd stocks is ₹7,545/6,001.

What is the Stock P/E of Apollo Hospitals Enterprise Ltd?

The Stock P/E of Apollo Hospitals Enterprise Ltd is 70.6.

What is the Book Value of Apollo Hospitals Enterprise Ltd?

The Book Value of Apollo Hospitals Enterprise Ltd is 571.

What is the Dividend Yield of Apollo Hospitals Enterprise Ltd?

The Dividend Yield of Apollo Hospitals Enterprise Ltd is 0.23 %.

What is the ROCE of Apollo Hospitals Enterprise Ltd?

The ROCE of Apollo Hospitals Enterprise Ltd is 17.1 %.

What is the ROE of Apollo Hospitals Enterprise Ltd?

The ROE of Apollo Hospitals Enterprise Ltd is 19.1 %.

What is the Face Value of Apollo Hospitals Enterprise Ltd?

The Face Value of Apollo Hospitals Enterprise Ltd is 5.00.